Early-Stage Trial Explores Stem Cell Therapy for Parkinson’s Disease
A first-of-its-kind Phase 1 clinical trial at Mass General Brigham is evaluating a personalized stem cell therapy for Parkinson’s disease, aiming to replace lost dopamine neurons using a patient’s own reprogrammed cells.
